Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C029790 |
2,2',3',4,4',5-hexachlorobiphenyl |
2,2',3',4,4',5-hexachlorobiphenyl inhibits the reaction [Estradiol results in increased expression of BRCA1 mRNA] | decreases reaction|increases expression | 12473173
|
C014024 |
2,4,5,2',4',5'-hexachlorobiphenyl |
2,4,5,2',4',5'-hexachlorobiphenyl inhibits the reaction [Estradiol results in increased expression of BRCA1 mRNA] | decreases reaction|increases expression | 12473173
|
C425784 |
2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole |
[2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole binds to AHR protein] which results in increased activity of BRCA1 protein | affects binding|increases activity | 18259752
|
C425784 |
2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole |
BRCA1 protein promotes the reaction [2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole results in increased expression of CYP1A1 mRNA] | increases expression|increases reaction | 16567799
|
C091768 |
3'-methoxy-4'-nitroflavone |
3'-methoxy-4'-nitroflavone inhibits the reaction [Estradiol results in increased expression of BRCA1 mRNA] | decreases reaction|increases expression | 16489025
|
C065250 |
4-hydroxy-equilenin |
4-hydroxy-equilenin results in decreased expression of BRCA1 mRNA | decreases expression | 15135645
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of BRCA1 mRNA | affects expression | 17562736
|
D000082 |
Acetaminophen |
Acetaminophen results in decreased expression of BRCA1 mRNA | decreases expression | 17942131
|
C011512 |
alpha-naphthoflavone |
alpha-naphthoflavone inhibits the reaction [Estradiol results in increased expression of BRCA1 mRNA] | decreases reaction|increases expression | 16489025
|
C011512 |
alpha-naphthoflavone |
alpha-naphthoflavone inhibits the reaction [[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased activity of BRCA1 protein] | affects binding|decreases reaction|increases activity | 18259752
|
D015081 |
2-Naphthylamine |
2-Naphthylamine results in decreased expression of BRCA1 mRNA | decreases expression | 18247414
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of BRCA1 mRNA | affects expression | 16483693
|
C006632 |
arsenic trioxide |
arsenic trioxide results in increased expression of BRCA1 mRNA | increases expression | 20458559
|
D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite affects the expression of BRCA1 mRNA | affects expression | 17331233
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene inhibits the reaction [Estradiol results in increased expression of BRCA1 mRNA] | decreases reaction|increases expression | 16489025
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of BRCA1 mRNA | decreases expression | 18247414 20064835 11782367
|
D001564 |
Benzo(a)pyrene |
TP53 protein promotes the reaction [Benzo(a)pyrene results in decreased expression of BRCA1 mRNA] | decreases expression|increases reaction | 11782367
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of BRCA1 mRNA | decreases expression | 17942131
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of BRCA1 mRNA | increases expression | 20713471
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of BRCA1 mRNA | decreases expression | 20382639 11782367
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of BRCA1 protein | decreases expression | 11782367
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
TP53 protein promotes the reaction [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of BRCA1 mRNA] | decreases expression|increases reaction | 11782367
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
TP53 protein promotes the reaction [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of BRCA1 protein] | decreases expression|increases reaction | 11782367
|
C006780 |
bisphenol A |
bisphenol A results in decreased expression of BRCA1 mRNA | decreases expression | 16029874
|
C006780 |
bisphenol A |
BRCA1 protein affects the reaction [bisphenol A results in increased activity of ESR1 protein] | affects reaction|increases activity | 20868731
|
C006780 |
bisphenol A |
BRCA1 protein affects the susceptibility to bisphenol A | affects response to substance | 20868731
|
C006780 |
bisphenol A |
BRCA1 gene mutant form results in increased susceptibility to bisphenol A | increases response to substance | 20868731
|
C005961 |
bis(tri-n-butyltin)oxide |
bis(tri-n-butyltin)oxide results in decreased expression of BRCA1 mRNA | decreases expression | 17942131
|
D002166 |
Camptothecin |
Camptothecin results in decreased expression of BRCA1 mRNA | decreases expression | 10344722
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in increased expression of BRCA1 mRNA | increases expression | 17484886
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride affects the expression of BRCA1 mRNA | affects expression | 12734012
|
D003513 |
Cycloheximide |
Cycloheximide inhibits the reaction [Nitrogen Mustard Compounds results in decreased expression of BRCA1 mRNA] | decreases expression|decreases reaction | 10344722
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of BRCA1 mRNA | decreases expression | 17942131
|
C004742 |
daidzein |
daidzein results in increased expression of BRCA1 mRNA | increases expression | 17266178
|
C014347 |
decitabine |
decitabine affects the localization of BRCA1 protein modified form | affects localization | 17991895
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in increased expression of BRCA1 mRNA | increases expression | 17854601
|
D004052 |
Diethylnitrosamine |
RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of BRCA1 mRNA] | decreases reaction|increases expression | 17854601
|
D004317 |
Doxorubicin |
Doxorubicin results in decreased expression of BRCA1 mRNA | decreases expression | 15607317 10344722
|
D004958 |
Estradiol |
2,2',3',4,4',5-hexachlorobiphenyl inhibits the reaction [Estradiol results in increased expression of BRCA1 mRNA] | decreases reaction|increases expression | 12473173
|
D004958 |
Estradiol |
2,4,5,2',4',5'-hexachlorobiphenyl inhibits the reaction [Estradiol results in increased expression of BRCA1 mRNA] | decreases reaction|increases expression | 12473173
|
D004958 |
Estradiol |
3'-methoxy-4'-nitroflavone inhibits the reaction [Estradiol results in increased expression of BRCA1 mRNA] | decreases reaction|increases expression | 16489025
|
D004958 |
Estradiol |
AHR protein affects the reaction [Estradiol results in increased expression of BRCA1 mRNA] | affects reaction|increases expression | 16489025
|
D004958 |
Estradiol |
[AHR protein binds to ESR1 protein] affects the reaction [Estradiol results in increased expression of BRCA1 mRNA] | affects binding|affects reaction|increases expression | 16489025
|
D004958 |
Estradiol |
alpha-naphthoflavone inhibits the reaction [Estradiol results in increased expression of BRCA1 mRNA] | decreases reaction|increases expression | 16489025
|
D004958 |
Estradiol |
Benzo(a)pyrene inhibits the reaction [Estradiol results in increased expression of BRCA1 mRNA] | decreases reaction|increases expression | 16489025
|
D004958 |
Estradiol |
BRCA1 protein affects the reaction [Estradiol promotes the reaction [ESR1 protein binds to NCOA3 protein]] | affects binding|affects reaction|increases reaction | 18997820
|
D004958 |
Estradiol |
BRCA1 protein affects the reaction [Estradiol results in increased expression of CCND1 mRNA] | affects reaction|increases expression | 18997820
|
D004958 |
Estradiol |
BRCA1 protein affects the reaction [Estradiol results in increased expression of MYC mRNA] | affects reaction|increases expression | 18997820
|
D004958 |
Estradiol |
BRCA1 protein affects the reaction [Estradiol results in increased expression of PGR mRNA] | affects reaction|increases expression | 18997820
|
D004958 |
Estradiol |
BRCA1 protein inhibits the reaction [Estradiol results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 18997820
|
D004958 |
Estradiol |
BRCA1 protein inhibits the reaction [Estradiol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 18997820
|
D004958 |
Estradiol |
BRCA1 protein inhibits the reaction [Estradiol results in increased phosphorylation of and results in increased activity of MAPK3 protein] | decreases reaction|increases activity|increases phosphorylation | 18997820
|
D004958 |
Estradiol |
BRCA1 protein promotes the reaction [indole-3-carbinol inhibits the reaction [Estradiol results in increased activity of ESR1 protein]] | decreases reaction|increases activity|increases reaction | 11110848
|
D004958 |
Estradiol |
Estradiol affects the localization of BRCA1 protein | affects localization | 16061635
|
D004958 |
Estradiol |
Estradiol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to BRCA1 promoter]] | affects binding|decreases reaction|increases reaction | 16489025
|
D004958 |
Estradiol |
Estradiol promotes the reaction [EP300 protein binds to BRCA1 promoter] | affects binding|increases reaction | 16489025
|
D004958 |
Estradiol |
Estradiol promotes the reaction [ESR1 protein binds to BRCA1 promoter] | affects binding|increases reaction | 16489025
|
D004958 |
Estradiol |
Estradiol promotes the reaction [ESR1 protein binds to CREBBP protein binds to BRCA1 protein] | affects binding|increases reaction | 16417649
|
D004958 |
Estradiol |
Estradiol promotes the reaction [NCOA1 protein binds to BRCA1 promoter] | affects binding|increases reaction | 16489025
|
D004958 |
Estradiol |
Estradiol results in increased expression of BRCA1 mRNA | increases expression | 12473173 17266178 16489025
|
D004958 |
Estradiol |
fulvestrant inhibits the reaction [Estradiol results in increased expression of BRCA1 mRNA] | decreases reaction|increases expression | 12473173
|
D004958 |
Estradiol |
PCB 180 inhibits the reaction [Estradiol results in increased expression of BRCA1 mRNA] | decreases reaction|increases expression | 12473173
|
D004958 |
Estradiol |
[Tetrachlorodibenzodioxin co-treated with Estradiol] promotes the reaction [HDAC1 protein binds to BRCA1 promoter] | affects binding|affects cotreatment|increases reaction | 16489025
|
D004958 |
Estradiol |
Tetrachlorodibenzodioxin inhibits the reaction [Estradiol promotes the reaction [EP300 protein binds to BRCA1 promoter]] | affects binding|decreases reaction|increases reaction | 16489025
|
D004958 |
Estradiol |
Tetrachlorodibenzodioxin inhibits the reaction [Estradiol promotes the reaction [NCOA1 protein binds to BRCA1 promoter]] | affects binding|decreases reaction|increases reaction | 16489025
|
D004958 |
Estradiol |
Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of BRCA1 mRNA] | decreases reaction|increases expression | 16489025 12473173
|
D005047 |
Etoposide |
BRCA1 protein mutant form inhibits the reaction [Etoposide results in increased expression of CDK2 protein] | decreases reaction|increases expression | 16417649
|
D005047 |
Etoposide |
BRCA1 protein mutant form inhibits the reaction [Etoposide results in increased expression of RAD52 protein] | decreases reaction|increases expression | 16417649
|
D005047 |
Etoposide |
BRCA1 protein mutant form inhibits the reaction [Etoposide results in increased expression of RAD54L protein] | decreases reaction|increases expression | 16417649
|
D005047 |
Etoposide |
BRCA1 protein mutant form inhibits the reaction [Etoposide results in increased expression of XRCC2 protein] | decreases reaction|increases expression | 16417649
|
D005047 |
Etoposide |
BRCA1 protein mutant form inhibits the reaction [Etoposide results in increased expression of XRCC3 protein] | decreases reaction|increases expression | 16417649
|
D005047 |
Etoposide |
BRCA1 protein mutant form inhibits the reaction [Etoposide results in increased expression of XRCC4 protein] | decreases reaction|increases expression | 16417649
|
D005047 |
Etoposide |
Etoposide results in decreased expression of BRCA1 mRNA | decreases expression | 15607317
|
D005419 |
Flavonoids |
Flavonoids results in increased expression of BRCA1 mRNA | increases expression | 18035473
|
D005472 |
Fluorouracil |
Fluorouracil results in decreased expression of BRCA1 mRNA | decreases expression | 15607317 17982676
|
D005472 |
Fluorouracil |
Fluorouracil results in increased expression of BRCA1 mRNA | increases expression | 16101138 16557594
|
D005472 |
Fluorouracil |
TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of BRCA1 mRNA] | decreases expression|decreases reaction | 17982676
|
C070081 |
fulvestrant |
fulvestrant inhibits the reaction [Estradiol results in increased expression of BRCA1 mRNA] | decreases reaction|increases expression | 12473173
|
D019833 |
Genistein |
Genistein results in increased expression of BRCA1 mRNA | increases expression | 17266178 16434996
|
D019833 |
Genistein |
Genistein results in increased expression of BRCA1 protein | increases expression | 16434996
|
D019833 |
Genistein |
[indole-3-carbinol co-treated with Genistein] results in increased expression of BRCA1 protein | affects cotreatment|increases expression | 16434996
|
D006861 |
Hydrogen Peroxide |
BRCA1 protein results in decreased susceptibility to Hydrogen Peroxide | decreases response to substance | 15520196
|
C016517 |
indole-3-carbinol |
BRCA1 protein promotes the reaction [indole-3-carbinol inhibits the reaction [Estradiol results in increased activity of ESR1 protein]] | decreases reaction|increases activity|increases reaction | 11110848
|
C016517 |
indole-3-carbinol |
[indole-3-carbinol co-treated with Genistein] results in increased expression of BRCA1 protein | affects cotreatment|increases expression | 16434996
|
C016517 |
indole-3-carbinol |
indole-3-carbinol promotes the reaction [AHR protein binds to BRCA1 protein] | affects binding|increases reaction | 18259752
|
C016517 |
indole-3-carbinol |
indole-3-carbinol results in increased expression of BRCA1 mRNA | increases expression | 16434996
|
C016517 |
indole-3-carbinol |
indole-3-carbinol results in increased expression of BRCA1 protein | increases expression | 11110848 16434996
|
D008748 |
Methylcholanthrene |
Methylcholanthrene promotes the reaction [AHR protein binds to BRCA1 protein] | affects binding|increases reaction | 18259752
|
D008748 |
Methylcholanthrene |
Methylcholanthrene results in increased expression of BRCA1 mRNA | increases expression | 20713471
|
D008769 |
Methylnitronitrosoguanidine |
Methylnitronitrosoguanidine results in increased expression of BRCA1 mRNA | increases expression | 12634122
|
D015741 |
Metribolone |
Metribolone results in increased expression of BRCA1 mRNA | increases expression | 17010196
|
D009538 |
Nicotine |
Nicotine results in decreased expression of BRCA1 mRNA | decreases expression | 18247414
|
D009588 |
Nitrogen Mustard Compounds |
Cycloheximide inhibits the reaction [Nitrogen Mustard Compounds results in decreased expression of BRCA1 mRNA] | decreases expression|decreases reaction | 10344722
|
D009588 |
Nitrogen Mustard Compounds |
Nitrogen Mustard Compounds results in decreased expression of BRCA1 mRNA | decreases expression | 10344722
|
C122062 |
NSC 674495 |
BRCA1 protein promotes the reaction [NSC 674495 results in increased expression of CYP1A1 mRNA] | increases expression|increases reaction | 16567799
|
C122062 |
NSC 674495 |
NSC 674495 promotes the reaction [AHR protein binds to BRCA1 protein] | affects binding|increases reaction | 18259752
|
D010100 |
Oxygen |
Oxygen deficiency results in decreased expression of BRCA1 protein | decreases expression | 17599377
|
D017239 |
Paclitaxel |
Paclitaxel results in decreased expression of BRCA1 mRNA | decreases expression | 15607317
|
D010269 |
Paraquat |
BRCA1 protein results in decreased susceptibility to Paraquat | decreases response to substance | 15520196
|
C410127 |
PCB 180 |
PCB 180 inhibits the reaction [Estradiol results in increased expression of BRCA1 mRNA] | decreases reaction|increases expression | 12473173
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of BRCA1 mRNA | increases expression | 17950772
|
C006253 |
pirinixic acid |
PPARA protein promotes the reaction [pirinixic acid results in increased expression of BRCA1 mRNA] | increases expression|increases reaction | 17950772
|
D011794 |
Quercetin |
Quercetin results in increased expression of BRCA1 mRNA | increases expression | 14715546
|
D012402 |
Rotenone |
Rotenone results in increased expression of BRCA1 mRNA | increases expression | 18191903
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of BRCA1 mRNA | increases expression | 12760830
|
C017947 |
sodium arsenite |
sodium arsenite affects the expression of BRCA1 mRNA | affects expression | 16507464
|
C017947 |
sodium arsenite |
[sodium arsenite co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of BRCA1 mRNA | affects cotreatment|decreases expression | 16368122
|
D018038 |
Sodium Selenite |
Sodium Selenite results in decreased expression of BRCA1 mRNA | decreases expression | 10344722
|
D013467 |
Sulindac |
Sulindac results in decreased expression of BRCA1 mRNA | decreases expression | 16273229
|
D013629 |
Tamoxifen |
BRCA1 protein affects the reaction [Tamoxifen promotes the reaction [ESR1 protein binds to NCOA3 protein]] | affects binding|affects reaction|increases reaction | 18997820
|
D013629 |
Tamoxifen |
BRCA1 protein affects the reaction [Tamoxifen promotes the reaction [ESR1 protein binds to NCOR2 protein]] | affects binding|affects reaction|increases reaction | 18997820
|
D013629 |
Tamoxifen |
BRCA1 protein affects the reaction [Tamoxifen promotes the reaction [ESR1 protein binds to PHB2 protein]] | affects binding|affects reaction|increases reaction | 18997820
|
D013629 |
Tamoxifen |
BRCA1 protein affects the reaction [Tamoxifen promotes the reaction [NCOR2 protein binds to CCND1 promoter]] | affects binding|affects reaction|increases reaction | 18997820
|
D013629 |
Tamoxifen |
BRCA1 protein affects the reaction [Tamoxifen results in decreased expression of CCND1 mRNA] | affects reaction|decreases expression | 18997820
|
D013629 |
Tamoxifen |
BRCA1 protein affects the reaction [Tamoxifen results in decreased expression of MYC mRNA] | affects reaction|decreases expression | 18997820
|
D013629 |
Tamoxifen |
BRCA1 protein affects the reaction [Tamoxifen results in decreased expression of PGR mRNA] | affects reaction|decreases expression | 18997820
|
D013629 |
Tamoxifen |
BRCA1 protein results in increased susceptibility to Tamoxifen | increases response to substance | 18997820
|
D013749 |
Tetrachlorodibenzodioxin |
alpha-naphthoflavone inhibits the reaction [[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased activity of BRCA1 protein] | affects binding|decreases reaction|increases activity | 18259752
|
D013749 |
Tetrachlorodibenzodioxin |
ARNT protein affects the reaction [Tetrachlorodibenzodioxin promotes the reaction [BRCA1 protein binds to CYP1B1 promoter]] | affects binding|affects reaction|increases reaction | 16567799
|
D013749 |
Tetrachlorodibenzodioxin |
BRCA1 protein promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] | increases expression|increases reaction | 16567799
|
D013749 |
Tetrachlorodibenzodioxin |
BRCA1 protein promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA] | increases expression|increases reaction | 16567799
|
D013749 |
Tetrachlorodibenzodioxin |
Estradiol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to BRCA1 promoter]] | affects binding|decreases reaction|increases reaction | 16489025
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Estradiol] promotes the reaction [HDAC1 protein binds to BRCA1 promoter] | affects binding|affects cotreatment|increases reaction | 16489025
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin inhibits the reaction [Estradiol promotes the reaction [EP300 protein binds to BRCA1 promoter]] | affects binding|decreases reaction|increases reaction | 16489025
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin inhibits the reaction [Estradiol promotes the reaction [NCOA1 protein binds to BRCA1 promoter]] | affects binding|decreases reaction|increases reaction | 16489025
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of BRCA1 mRNA] | decreases reaction|increases expression | 16489025 12473173
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to BRCA1 promoter] | affects binding|increases reaction | 16489025
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to BRCA1 protein] | affects binding|increases reaction | 18259752
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin promotes the reaction [BRCA1 protein binds to CYP1A1 promoter] | affects binding|increases reaction | 16567799
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin promotes the reaction [BRCA1 protein binds to CYP1B1 promoter] | affects binding|increases reaction | 16567799
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin promotes the reaction [HDAC1 protein binds to BRCA1 promoter] | affects binding|increases reaction | 16489025
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of BRCA1 mRNA | increases expression | 19465110
|
D013749 |
Tetrachlorodibenzodioxin |
BRCA1 protein promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] | increases expression|increases reaction | 16567799
|
D013755 |
Tetradecanoylphorbol Acetate |
[sodium arsenite co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of BRCA1 mRNA | affects cotreatment|decreases expression | 16368122
|
D019284 |
Thapsigargin |
Thapsigargin results in increased expression of BRCA1 mRNA | increases expression | 16434996
|
D019284 |
Thapsigargin |
Thapsigargin results in increased expression of BRCA1 protein | increases expression | 16434996
|
D014112 |
Toxaphene |
Toxaphene results in increased expression of BRCA1 mRNA | increases expression | 12473173
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of BRCA1 mRNA | increases expression | 16054129
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of BRCA1 mRNA | increases expression | 17198874
|
D014415 |
Tunicamycin |
Tunicamycin results in increased expression of BRCA1 protein | increases expression | 16434996
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Sulindac |
11.10 | 14745880 |
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
11.10 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.30 | 15322242 11752688 14514962 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.00 | 18287403 |
MESH:D058186 |
Acute Kidney Injury |
|
Sulindac |
3.81 | 7897758 |
MESH:D055371 |
Acute Lung Injury |
|
Oxygen |
7.50 | 16759491 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
7.50 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
21.56 | 11798837 19825857 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
21.56 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
daidzein |
21.56 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
21.56 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
21.56 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
21.56 | 17638652 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
21.56 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Sulindac |
21.56 | 11910360 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
13.14 | 6695378 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
13.14 | 10737359 6695378 |
MESH:D000236 |
Adenoma |
|
Methylcholanthrene |
13.14 | 10545420 6695378 |
MESH:D000236 |
Adenoma |
|
Sulindac |
13.14 | 10223192 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
14.01 | 17620307 19052882 19061943 17162532 16434500 18056438 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
14.01 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
14.01 | 16835633 |
MESH:D011125 |
Adenomatous Polyposis Coli |
|
Sulindac |
4.11 | 17611924 12394442 16460482 11874996 15623613 11535846 19003578 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.12 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.32 | 17306315 16712894 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Paraquat |
7.44 | 11874814 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Toxaphene |
7.44 | 16132792 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.01 | 21441931 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.16 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
Nicotine |
3.14 | 16627626 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
7.05 | 15504547 16511603 17963324 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
7.05 | 11748828 |
MESH:D000743 |
Anemia, Hemolytic |
|
Quercetin |
3.73 | 17084956 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.27 | 10982225 |
MESH:D000860 |
Anoxia |
|
Oxygen |
4.49 | 20872349 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.52 | 19183758 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
2.71 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.11 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.15 | 16456186 |
MESH:D001260 |
Ataxia Telangiectasia |
|
Quercetin |
4.41 | 15336622 |
MESH:D050197 |
Atherosclerosis |
|
Methylcholanthrene |
5.97 | 11922910 |
MESH:D050197 |
Atherosclerosis |
|
Oxygen |
5.97 | 16391483 |
MESH:D001284 |
Atrophy |
|
fulvestrant |
4.31 | 11514358 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.50 | 18445737 |
MESH:D001327 |
Autoimmune Diseases |
|
Quercetin |
3.86 | 19761891 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
3.86 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
17.79 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
17.79 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
17.79 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
17.79 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.21 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.38 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
10.24 | 14601052 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Etoposide |
10.24 | 14601052 |
MESH:D001859 |
Bone Neoplasms |
|
Paclitaxel |
4.04 | 15867366 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.36 | 11985600 |
MESH:D001913 |
Bowen's Disease |
|
Sulindac |
4.78 | 11207687 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.32 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
marker/mechanism |
|
| 20135344 18066063 15894690 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
19.61 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
19.61 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
19.61 | 18320071 19208741 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
19.61 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
19.61 | 16264153 17983394 16096432 15692762 15939500 17426702 18628466 16115903 18695136 15136595 17369602 15567936 19526202 11325840 18234424 15993339 16595493 16826403 16935488 15668708 18382427 15634643 15994142 16322301 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
19.61 | 19861407 14630087 17261762 12948864 17289903 18497071 16675129 17018787 |
MESH:D001943 |
Breast Neoplasms |
|
Etoposide |
19.61 | 16322251 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
19.61 | 16110121 16595493 18357371 18608205 19217205 15136595 16557594 |
MESH:D001943 |
Breast Neoplasms |
|
fulvestrant |
19.61 | 18984771 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
19.61 | 16873071 16541309 17200150 |
MESH:D001943 |
Breast Neoplasms |
|
indole-3-carbinol |
19.61 | 16082211 |
MESH:D001943 |
Breast Neoplasms |
|
Methylcholanthrene |
19.61 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Oxygen |
19.61 | 17263869 |
MESH:D001943 |
Breast Neoplasms |
|
Paclitaxel |
19.61 | 16115903 16273361 11325840 15136595 18323546 16244791 18234424 18223236 |
MESH:D001943 |
Breast Neoplasms |
|
Quercetin |
19.61 | 18628248 |
MESH:D001943 |
Breast Neoplasms |
|
Sulindac |
19.61 | 16642371 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
19.61 | 20859285 18351453 18425577 16818667 21152245 19189210 19289846 17242785 19200415 19244106 19288272 18821012 16873071 19011961 19103187 11161223 18984771 16202921 20005174 19155303 17440819 20135344 20390343 20065188 17049068 18855134 19410462 18629630 19115204 19066611 15565566 18815881 15668708 19142967 20544844 17893378 19084267 19221464 19487384 19059307 17261762 16273361 21138602 18997820 19189212 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
19.61 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
19.61 | 16166294 16443354 16873071 |
OMIM:604370 |
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1 |
marker/mechanism |
|
| |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.02 | 16813970 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
3.81 | 11589617 |
MESH:D002105 |
Cadmium Poisoning |
|
Quercetin |
4.97 | 16962696 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
3.90 | 16111702 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.23 | 10355542 16227642 15721981 15700767 16097048 18705752 16050911 15673190 16011737 16192424 3786805 16124888 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
10.43 | 16051944 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
10.43 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
11.37 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Methylcholanthrene |
11.37 | 10545420 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
11.37 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
3.95 | 19066611 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.58 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
29.27 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
29.27 | 15553829 14691202 15073043 16217749 11135700 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
29.27 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
29.27 | 16830150 16935385 19822196 19919837 16540662 3084413 3581430 19052882 16807293 10672840 18506893 20727157 20007298 18210153 21159647 16569478 19519916 18393292 11831363 19208518 16288022 17055752 19394651 17761372 20935162 20214788 16779866 16878318 17173139 20432363 20524982 18056438 19171122 20512989 20084675 19383236 19539802 20514400 16698587 18978308 17428255 18971187 19335982 18691550 19701751 18494052 18785209 16681979 17138121 19107877 17978847 16328049 17162532 18788625 10737359 19418558 18665156 16502159 20101231 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
29.27 | 16234567 17876044 18059187 16023760 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
29.27 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
29.27 | 17045692 17971768 16799960 17088986 16332177 18930000 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
29.27 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Paclitaxel |
29.27 | 16313753 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Quercetin |
29.27 | 19519916 12508355 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
29.27 | 15276417 17306315 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
29.27 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
29.27 | 1917145 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.42 | 17123778 |
MESH:D021441 |
Carcinoma, Pancreatic Ductal |
|
Quercetin |
4.40 | 17234771 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.30 | 19014326 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
5.69 | 16201981 1485588 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
5.69 | 18695887 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
3.62 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
18.88 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
18.88 | 19215824 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
18.88 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
18.88 | 18986760 17066447 16280240 16757204 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
18.88 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tetradecanoylphorbol Acetate |
18.88 | 18922899 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
18.88 | 16051514 16096774 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.12 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Quercetin |
5.67 | 19794523 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
5.67 | 18670907 18850075 16120746 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.14 | 17924179 16612575 15792986 15476868 17007740 16731534 17974986 17519947 16952015 16651473 16278810 17329180 15811867 17131338 16242529 17308081 17928571 16364871 16455267 16109756 17351982 17382496 18627295 16269455 15505089 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.72 | 16243910 17334414 |
MESH:D002318 |
Cardiovascular Diseases |
|
daidzein |
10.02 | 16332659 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
10.02 | 16332659 |
MESH:D002318 |
Cardiovascular Diseases |
|
Hydrogen Peroxide |
10.02 | 16936243 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
6.04 | 10977129 |
MESH:D002386 |
Cataract |
|
Tretinoin |
6.04 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
25.62 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
25.62 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
25.62 | 17174075 2727394 21159647 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
25.62 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylcholanthrene |
25.62 | 16192471 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylnitronitrosoguanidine |
25.62 | 2727394 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
25.62 | 19524636 20056578 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.02 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
7.73 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
7.73 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
6.33 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
6.33 | 19176532 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.58 | 16461808 |
MESH:D019457 |
Chromosome Breakage |
marker/mechanism |
|
| 15894690 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
4.20 | 15894690 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
4.87 | 12621046 15668235 16354765 15340226 8697196 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
4.87 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.16 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
9.59 | 17616700 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
9.59 | 15001691 17169374 16510598 17016597 17725105 17018589 16340194 18772588 17172411 17287894 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
9.59 | 17182828 |
MESH:D003110 |
Colonic Neoplasms |
|
Quercetin |
9.59 | 11134977 19056647 19440933 17191121 15741050 16640504 17148506 |
MESH:D003110 |
Colonic Neoplasms |
|
Sulindac |
9.59 | 12458338 12902858 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
9.30 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
9.30 | 18981723 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
9.30 | 18259882 18802399 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
9.30 | 15289873 16282729 17594712 18383874 18949393 16524972 17255274 18802399 14970324 17454858 15148649 18509181 17016601 16303861 18288408 17695437 17094418 18448328 17401013 20501625 16331619 16391804 |
MESH:D015179 |
Colorectal Neoplasms |
|
Paclitaxel |
9.30 | 18802399 |
MESH:D015179 |
Colorectal Neoplasms |
|
Quercetin |
9.30 | 18095365 18852136 |
MESH:D015179 |
Colorectal Neoplasms |
|
Sulindac |
9.30 | 18059344 10666051 11197048 11076880 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.58 | 14669216 17141729 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
3.65 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
3.30 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.30 | 15322242 10048152 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
3.30 | 9125849 9211117 9664655 16925845 14991402 9224671 8800419 9142499 17551590 10589399 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.23 | 16733453 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
3.57 | 15213294 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
3.81 | 19031437 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.14 | 18249437 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
3.30 | 16285004 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Quercetin |
3.27 | 19496084 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
daidzein |
8.82 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
8.82 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
8.82 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
8.82 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
7.25 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
7.25 | 19279558 |
MESH:D003930 |
Diabetic Retinopathy |
|
Sulindac |
4.64 | 17621415 12861449 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
12.56 | 19416960 19923254 11287661 17906064 18071297 12594235 19739265 16109766 14725611 11834606 16781746 14986274 10915739 2444490 11529661 11421492 12705907 15968718 11743745 16177239 11739529 19164858 11461765 16227642 12153990 16081117 12540782 15619225 18713872 19085960 14550746 17522070 10774834 12958197 10663392 19420014 19370779 17562736 16485898 12392966 16393943 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
12.56 | 2869522 7120509 15027814 6623471 10092053 11566570 9327722 3786805 6884620 15998439 4309450 16227642 10915739 15968718 17522070 3732212 7179309 19336974 21278145 16177239 19085960 7440962 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
12.56 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
12.56 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
12.56 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
12.56 | 20420201 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.52 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
6.68 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
6.68 | 11462148 |
MESH:D004417 |
Dyspnea |
|
Oxygen |
4.26 | 20016425 |
MESH:D020821 |
Dystonic Disorders |
|
Nicotine |
5.36 | 17881519 |
MESH:D004487 |
Edema |
|
pirinixic acid |
8.58 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
8.58 | 11000095 12711302 |
MESH:D004487 |
Edema |
|
Tetradecanoylphorbol Acetate |
8.58 | 9599246 8273558 8113982 16716910 11698051 15177302 7812673 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
10.03 | 15322242 18230668 16714409 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
10.03 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
3.01 | 19031437 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
4.54 | 19294695 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
4.02 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
daidzein |
24.10 | 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
24.10 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
24.10 | 11473722 18566989 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
24.10 | 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
24.10 | 17893378 20544844 16202921 19155303 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
24.10 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Sulindac |
7.55 | 15652904 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
7.55 | 10568697 9294722 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
4.58 | 18037988 |
MESH:D007172 |
Erectile Dysfunction |
|
daidzein |
4.48 | 14972507 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.54 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
15.06 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
15.06 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
15.06 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
15.06 | 16337965 16785472 15173087 16481741 17638652 |
MESH:D004938 |
Esophageal Neoplasms |
|
Paclitaxel |
15.06 | 16481741 |
MESH:D004938 |
Esophageal Neoplasms |
|
Sulindac |
15.06 | 12235107 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
7.40 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
7.40 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
24.17 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
24.17 | 61145 16045604 19224547 17595544 12631006 15959796 12795759 16239168 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
24.17 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
24.17 | 21071580 20387270 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
24.17 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
24.17 | 19224547 14986274 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
2.87 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
2.91 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Sulindac |
11.07 | 14745880 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
11.07 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
16.28 | 19069698 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Sulindac |
16.28 | 19069698 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
16.28 | 19069698 |
MESH:D005354 |
Fibrosarcoma |
|
Methylcholanthrene |
4.37 | 14633661 10962813 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
21.91 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
21.91 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Quercetin |
21.91 | 19474275 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
21.91 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
21.91 | 17994277 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
3.72 | 16904648 |
MESH:D005739 |
Gas Poisoning |
|
Oxygen |
4.64 | 20016425 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.10 | 16983495 |
MESH:D005764 |
Gastroesophageal Reflux |
|
Sulindac |
4.47 | 11910360 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.11 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.65 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
13.80 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
13.80 | 16598420 |
MESH:D005909 |
Glioblastoma |
|
Quercetin |
13.80 | 19804834 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
13.80 | 17312396 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
5.33 | 16145905 |
MESH:D005910 |
Glioma |
|
Quercetin |
5.33 | 17643826 |
MESH:D005911 |
Gliosis |
|
Paraquat |
4.59 | 11124998 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.02 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
15.20 | 19215824 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
15.20 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
15.20 | 15162350 18337622 15102660 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
15.20 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.58 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
9.20 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
9.20 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
9.20 | 9664655 14991402 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.08 | 18006777 12587719 16495754 16144979 17875725 16244371 16330681 17888722 16244372 16707910 18674790 16879835 14766674 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
5.82 | 17481944 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
5.82 | 20558911 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.40 | 15692506 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
3.85 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
2.83 | 11000095 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.06 | 19900420 19110552 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
6.44 | 19772884 18467677 19176532 16221962 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
6.44 | 16120746 15340226 12621046 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.45 | 15709030 |
MESH:D006561 |
Herpes Simplex |
|
Etoposide |
4.00 | 10809021 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
13.71 | 17606976 18501091 15147373 |
MESH:D006689 |
Hodgkin Disease |
|
Etoposide |
13.71 | 18180244 17606976 15147373 16200630 16135485 |
MESH:D006689 |
Hodgkin Disease |
|
Nitrogen Mustard Compounds |
13.71 | 16794504 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
13.71 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.18 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.47 | 15340226 16959395 16354765 18606429 8697196 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
6.13 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
6.13 | 16870215 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
3.97 | 16899240 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.01 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
7.60 | 20558911 |
MESH:D006943 |
Hyperglycemia |
|
Quercetin |
7.60 | 11834736 18262572 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
10.35 | 10903974 |
MESH:D006973 |
Hypertension |
|
daidzein |
10.35 | 17169123 |
MESH:D006973 |
Hypertension |
|
Quercetin |
10.35 | 18356687 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
10.35 | 18850075 18670907 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.54 | 15338365 |
MESH:D007248 |
Infertility, Male |
|
2,2',3',4,4',5-hexachlorobiphenyl |
17.00 | 12948891 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
17.00 | 17581917 |
MESH:D007248 |
Infertility, Male |
|
fulvestrant |
17.00 | 11514358 |
MESH:D007248 |
Infertility, Male |
|
Paraquat |
17.00 | 4850670 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
17.00 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
15.78 | 18785209 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
15.78 | 17296493 |
MESH:D007249 |
Inflammation |
|
Sulindac |
15.78 | 3291741 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
15.78 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
15.78 | 12200463 12878042 |
MESH:D007249 |
Inflammation |
|
Tetradecanoylphorbol Acetate |
15.78 | 8273558 7812673 15177302 7562506 11698051 |
MESH:D007251 |
Influenza, Human |
|
Quercetin |
3.93 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
14.47 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
14.47 | 16393666 16627594 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
14.47 | 16306350 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
14.47 | 14714311 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.22 | 17994277 |
MESH:D007414 |
Intestinal Neoplasms |
|
Sulindac |
4.14 | 10213222 12584176 12663524 12351151 10223192 12628509 |
MESH:D007417 |
Intestinal Polyps |
|
Sulindac |
4.46 | 12394442 11245490 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
8.24 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
8.24 | 17551590 15992940 |
MESH:D007627 |
Keloid |
|
Quercetin |
4.40 | 17086741 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
3.86 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
19.32 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
19.32 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
19.32 | 15369732 15699352 16775033 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
19.32 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
Quercetin |
19.32 | 16962696 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
19.32 | 20008137 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
8.44 | 16707910 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Hydrogen Peroxide |
8.44 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
13.96 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
13.96 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
13.96 | 16985049 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
13.96 | 18625569 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
16.39 | 15070760 |
MESH:D007938 |
Leukemia |
|
decitabine |
16.39 | 19235587 18980019 |
MESH:D007938 |
Leukemia |
|
Genistein |
16.39 | 18980019 17468513 |
MESH:D007938 |
Leukemia |
|
Quercetin |
16.39 | 17468513 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
16.39 | 17143497 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
4.58 | 16085563 |
MESH:D007945 |
Leukemia, Lymphoid |
|
Toxaphene |
5.72 | 16132792 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.29 | 17077332 12560223 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
3.74 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.00 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
13.07 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
13.07 | 18454857 17236224 19117987 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
13.07 | 16482212 16932348 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
5.34 | 16467208 17050201 19850784 20471514 16968895 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
5.34 | 19010910 18460780 18206229 17679729 19387464 18704418 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
5.34 | 19850784 16294345 17596541 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
4.88 | 18055864 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
6.34 | 17649720 16891316 9834237 19075265 16112521 12679006 19035177 11161223 17217047 17869043 16823087 15213294 17712046 19225113 17107899 16966277 12712474 15748426 11468182 16331271 12018890 15336539 19642359 16330433 15622746 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
6.34 | 16766008 16140955 17712046 17506722 16788101 16935935 19642359 12679006 17368321 17217047 17107899 17301526 17339181 19075265 9834237 17294898 19035177 17649720 16331271 16823087 15748426 19225113 17361223 19029980 16891316 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
3.81 | 16882451 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
2.89 | 9224671 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
2.74 | 17567588 15342952 |
MESH:D008080 |
Liposarcoma |
|
Paclitaxel |
4.30 | 17353645 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
5.49 | 11903743 16221502 16943688 17157831 17174718 17334410 11408273 21278145 16239168 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
5.49 | 20032147 19638242 18522880 18665156 18407596 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
Sulindac |
3.85 | 12468960 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
13.75 | 17922224 18395914 18317297 18205269 14724832 18279442 14716833 17525996 16116963 17557913 15996030 15818738 18166357 18412020 14748882 18429990 17565644 12546737 15123356 12445421 17900296 12667390 16097048 18418968 15959796 12898905 18705752 13678700 11481614 15876570 17766677 18156304 18481824 12632512 16638106 16027843 17481882 17631135 17976157 17721639 12649538 10355542 17869086 16192424 15362042 17640975 18472094 15338365 20821823 15673190 12741479 18376398 16136751 16015684 12609069 12445418 18263696 18251166 15057751 15730626 18472332 18054572 16033810 17805973 12586293 16248980 18277467 15931870 17944888 12632514 15052691 17761835 18395095 15925388 16011737 18006644 18420326 18210741 18339082 14620537 15650968 12389079 12958196 17708605 15893842 17698563 18187930 14512876 17714472 15370692 12666154 17823541 14716496 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
13.75 | 16595196 16439617 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
13.75 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
13.75 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
13.75 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Quercetin |
13.75 | 12741479 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
13.75 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
13.75 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
13.75 | 16248980 18397230 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
7.88 | 12969438 12587719 19784758 11587558 16611625 16610002 19460945 19014921 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
7.88 | 15720792 16246199 15830285 16964402 17285989 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
7.88 | 17034775 |
MESH:D008107 |
Liver Diseases |
|
Sulindac |
7.88 | 14986274 16867024 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.61 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
7.77 | 16871587 17185352 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
7.77 | 14706259 16899240 |
MESH:D008113 |
Liver Neoplasms |
|
2,4,5,2',4',5'-hexachlorobiphenyl |
32.75 | 16835634 18644402 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
32.75 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
32.75 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
32.75 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
32.75 | 12112319 18978307 19499222 19090486 20137499 2422723 19642983 21071580 19833225 2862719 16942905 15885732 21047994 20434301 19256749 20118626 19427195 19850985 21167192 20501860 12771043 19551842 19073162 19294768 19690152 18644402 19255062 18754104 19996281 20101389 20492335 19638242 21278145 18648771 9163691 18977376 20583210 15175105 19426721 20452335 10737359 19254457 20405173 19812893 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
32.75 | 15113037 17045692 18383874 16603448 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
32.75 | 16377806 20007298 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Quercetin |
32.75 | 18980244 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
32.75 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
32.75 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
32.75 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
22.55 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
22.55 | 15583823 12014681 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
22.55 | 18775883 3124819 18079962 19126423 18544905 19519916 16267830 17942915 17854601 18308698 21159647 18093689 9362446 18164116 19004024 18253720 16842330 18282651 2563599 19539802 19009564 17174075 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
22.55 | 17085340 16842330 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Methylcholanthrene |
22.55 | 1399818 598648 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Quercetin |
22.55 | 19519916 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
22.55 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
2.91 | 15213294 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
2.78 | 19095001 |
MESH:D055370 |
Lung Injury |
|
Asbestos, Crocidolite |
7.67 | 17365036 |
MESH:D055370 |
Lung Injury |
|
Oxygen |
7.67 | 18339021 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
20.71 | 11798837 19825857 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
20.71 | 20869020 17053015 20064080 18520028 20135361 20464547 6695378 18816296 18569708 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
20.71 | 20512841 20970405 6695378 21163286 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
20.71 | 17418594 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
20.71 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Methylcholanthrene |
20.71 | 20970405 1399818 16271038 7750092 16337739 15390079 17909032 10545420 21163286 11893704 20512841 9230183 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
Quercetin |
20.71 | 16280456 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
20.71 | 15276417 16712894 19931552 17306315 17077188 |
MESH:D008175 |
Lung Neoplasms |
|
Sulindac |
20.71 | 19359593 15713900 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
20.71 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
20.71 | 11884234 19555203 |
MESH:D008175 |
Lung Neoplasms |
|
Tetradecanoylphorbol Acetate |
20.71 | 11807781 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.23 | 15086387 |
MESH:D008223 |
Lymphoma |
|
decitabine |
10.28 | 19470736 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
10.28 | 16098063 |
MESH:D008223 |
Lymphoma |
|
Etoposide |
10.28 | 12556972 12854902 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
3.54 | 14737004 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
7.41 | 17654614 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Paclitaxel |
7.41 | 14749477 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.01 | 15621674 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.20 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
14.79 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
14.79 | 17203775 11408345 16891317 11807958 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
14.79 | 14578162 12929590 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
14.79 | 19196723 19196722 16827153 11731420 14580682 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tetradecanoylphorbol Acetate |
14.79 | 8985016 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
10.73 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
10.73 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.53 | 17453147 |
MESH:D008545 |
Melanoma |
|
decitabine |
13.33 | 16505122 17785578 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
13.33 | 16827129 |
MESH:D008545 |
Melanoma |
|
Paclitaxel |
13.33 | 12025231 12040289 16342250 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
13.33 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Sulindac |
13.33 | 16642371 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
13.33 | 12393984 19393235 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
13.33 | 16752155 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
3.62 | 15990972 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.02 | 19513568 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
3.87 | 16940565 |
MESH:D008654 |
Mesothelioma |
|
Asbestos, Crocidolite |
5.57 | 16166281 16966607 18303189 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
5.57 | 17638057 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.21 | 16801185 |
MESH:D053842 |
Microsatellite Instability |
|
Methylnitronitrosoguanidine |
5.32 | 17671175 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
3.99 | 15792986 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
7.06 | 16381670 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
7.06 | 16757204 18986760 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.22 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
9.80 | 15949261 11468182 19549372 19417148 14977855 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
9.80 | 18172295 |
MESH:D009101 |
Multiple Myeloma |
|
Paclitaxel |
9.80 | 14749477 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
2.96 | 16239165 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.09 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
10.32 | 16105982 16882451 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
10.32 | 19010910 19157545 18608210 16882708 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
10.32 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
11.34 | 19429709 15857846 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
11.34 | 17141266 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
11.34 | 19151258 |
MESH:D009203 |
Myocardial Infarction |
|
Quercetin |
11.34 | 19595682 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.57 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
16.67 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
16.67 | 17141266 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
16.67 | 16411023 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Quercetin |
16.67 | 19207477 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
3.42 | 16624393 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
11.47 | 9029167 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
11.47 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
Paclitaxel |
11.47 | 15867366 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
11.47 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.30 | 19410462 |
MESH:D009369 |
Neoplasms |
therapeutic |
|
| 15520196 |
MESH:D009369 |
Neoplasms |
|
2,4,5,2',4',5'-hexachlorobiphenyl |
30.71 | 8820588 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
30.71 | 11141357 |
MESH:D009369 |
Neoplasms |
|
decitabine |
30.71 | 19116145 17925555 19470736 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
30.71 | 18600527 18239605 16928823 |
MESH:D009369 |
Neoplasms |
|
Nicotine |
30.71 | 16365874 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
30.71 | 17405874 |
MESH:D009369 |
Neoplasms |
|
Quercetin |
30.71 | 15185748 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
30.71 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Toxaphene |
30.71 | 8820588 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
30.71 | 16594593 16946489 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.12 | 20056578 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.43 | 19196722 19200415 19189210 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
8.49 | 17289903 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Nicotine |
8.49 | 16365874 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.22 | 16636307 16899518 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
3.86 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
7.70 | 19348381 18481113 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
7.70 | 15640375 16889571 |
MESH:D009410 |
Nerve Degeneration |
|
Paraquat |
7.18 | 16893418 |
MESH:D009410 |
Nerve Degeneration |
|
Rotenone |
7.18 | 17356569 18619942 15790535 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
25.06 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
25.06 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
25.06 | 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
25.06 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
25.06 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
9.91 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
9.91 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
9.91 | 9142499 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
2.95 | 15555623 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
11.43 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
11.43 | 20387270 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Sulindac |
11.43 | 16850258 17266991 |
MESH:D020078 |
Neurogenic Inflammation |
|
Quercetin |
3.84 | 17929310 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.54 | 20387270 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.04 | 16436463 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.65 | 20558911 |
MESH:D010014 |
Osteolysis |
|
Paclitaxel |
4.41 | 15867366 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
2.89 | 19401787 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
8.40 | 16169203 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Quercetin |
8.40 | 19495926 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
3.66 | 15930896 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.42 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
marker/mechanism |
|
| 17688236 15894690 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
23.34 | 12452020 16624393 19769630 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
23.34 | 19331143 19259094 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
23.34 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
23.34 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
Paclitaxel |
23.34 | 11161223 |
MESH:D010051 |
Ovarian Neoplasms |
|
Quercetin |
23.34 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
23.34 | 15276417 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
23.34 | 16936753 |
MESH:D010146 |
Pain |
|
Acetaminophen |
8.66 | 16870215 |
MESH:D010146 |
Pain |
|
Sulindac |
8.66 | 3291741 |
MESH:D010146 |
Pain |
|
Tretinoin |
8.66 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
29.26 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
29.26 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
29.26 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Etoposide |
29.26 | 19003803 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
29.26 | 15113037 16929163 16500647 19003803 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Quercetin |
29.26 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Sulindac |
29.26 | 16820089 11504793 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tetradecanoylphorbol Acetate |
29.26 | 15976015 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
29.26 | 15976015 |
MESH:D010212 |
Papilloma |
|
Hydrogen Peroxide |
7.79 | 12065085 |
MESH:D010212 |
Papilloma |
|
Tetradecanoylphorbol Acetate |
7.79 | 12065085 8330346 18922899 18404319 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
3.64 | 19927285 |
MESH:D010300 |
Parkinson Disease |
|
Paraquat |
4.77 | 11445065 11181820 15451049 15824117 16140633 12911755 16510128 11124998 |
MESH:D010300 |
Parkinson Disease |
|
Rotenone |
4.77 | 16140633 16412576 11445065 18191903 19114014 19232380 11535288 18619942 15451049 |
MESH:D010302 |
Parkinson Disease, Secondary |
|
Paraquat |
3.88 | 16190885 |
MESH:D020734 |
Parkinsonian Disorders |
|
Rotenone |
3.59 | 15574749 15795934 18197244 15927086 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.67 | 12520081 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
4.58 | 17983394 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Crocidolite |
4.34 | 10923243 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
4.58 | 17638057 |
MESH:D011014 |
Pneumonia |
|
Paraquat |
3.89 | 12504350 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.02 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
12.55 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
12.55 | 2563599 |
MESH:D011230 |
Precancerous Conditions |
|
Quercetin |
12.55 | 19056647 |
MESH:D011248 |
Pregnancy Complications |
|
Toxaphene |
5.31 | 2087686 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
7.64 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
7.64 | 11118676 11896295 11399792 11222880 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
4.17 | 17616702 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
8.86 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
8.86 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
marker/mechanism |
|
| 17585057 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
5.33 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
5.33 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
5.33 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
5.33 | 15897917 18437689 15749863 16888761 16868541 16729912 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
5.33 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Etoposide |
5.33 | 17172428 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
5.33 | 18626508 19082440 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
5.33 | 15256057 15378649 16925846 |
MESH:D011471 |
Prostatic Neoplasms |
|
Paclitaxel |
5.33 | 17136230 17172428 16356831 16729912 |
MESH:D011471 |
Prostatic Neoplasms |
|
Quercetin |
5.33 | 17292933 14715546 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
5.33 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
5.33 | 18760546 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
5.33 | 15067354 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.09 | 16636307 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.00 | 16882103 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.23 | 16723453 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.22 | 10548101 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Crocidolite |
5.07 | 17975199 15814490 17322281 17365031 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Paraquat |
5.07 | 17997886 16324872 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
3.53 | 18722050 15538739 18286688 16160472 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
3.67 | 17922066 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.09 | 19058328 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Oxygen |
7.72 | 17627322 18339021 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Paraquat |
7.72 | 11700416 |
MESH:D012135 |
Respiratory Sounds |
|
Paraquat |
3.51 | 11874814 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.30 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
Paraquat |
3.44 | 16458197 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
9.21 | 19155313 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
9.21 | 16283617 16116481 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.50 | 17203757 17710206 15675481 18313854 16767912 15625365 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
14.22 | 16646077 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
14.22 | 14601052 16326096 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Etoposide |
14.22 | 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.22 | 17846226 |
MESH:D012554 |
Schistosomiasis japonica |
|
Quercetin |
4.97 | 16862918 |
MESH:D012640 |
Seizures |
|
Nicotine |
3.42 | 17873105 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
22.64 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
22.64 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Hydrogen Peroxide |
22.64 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
22.64 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
22.64 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tetradecanoylphorbol Acetate |
22.64 | 11807781 18404319 12065085 8330346 8985016 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
22.64 | 16467112 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.01 | 15625365 17203757 16767912 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
3.72 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.47 | 19457130 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.35 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
9.14 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
9.14 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
9.14 | 19037991 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
9.14 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
9.14 | 19084572 18396642 17172411 17522103 15786421 19015929 16424979 18567086 17498489 16951190 |
MESH:D013274 |
Stomach Neoplasms |
|
Paclitaxel |
9.14 | 18506536 18396642 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
9.14 | 17261132 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.42 | 16684133 16045194 |
MESH:D013398 |
Sudden Infant Death |
|
Oxygen |
4.98 | 12563064 |
MESH:D024801 |
Tauopathies |
|
Camptothecin |
9.96 | 16930453 |
MESH:D024801 |
Tauopathies |
|
Paclitaxel |
9.96 | 16930453 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.33 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
17.85 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
17.85 | 17967635 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
17.85 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
17.85 | 17909728 16010429 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
17.85 | 16026305 17045167 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.11 | 19048282 |
OMIM:188890 |
TOBACCO ADDICTION, SUSCEPTIBILITY TO |
|
Nicotine |
4.31 | 16720336 11259349 16785264 |
MESH:D014029 |
Tobacco Use Disorder |
|
Nicotine |
4.90 | 18041664 17979512 15735609 18305452 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
8.19 | 16280240 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
8.19 | 16051514 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.40 | 15213294 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
2.86 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2-Naphthylamine |
24.00 | 11144890 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
24.00 | 12845720 20435036 12973940 11780464 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
24.00 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
24.00 | 17616700 19087683 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
24.00 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Quercetin |
24.00 | 16720314 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
24.00 | 11723127 16712894 16452187 17306315 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
24.00 | 17572228 8653321 16712894 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.46 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
18.64 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
indole-3-carbinol |
18.64 | 16082211 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
18.64 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
18.64 | 16129372 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
4.43 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Sulindac |
4.07 | 18645019 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
10.91 | 17785578 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
10.91 | 16752155 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.41 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
3.86 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.02 | 12125929 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
3.67 | 17334414 16364871 17678736 17638931 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.52 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.67 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.49 | 16287080 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
3.86 | 17120751 |